Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Investment Income: 2022-2025

Historic Non Operating Investment Income for Biofrontera (BFRI) over the last 2 years, with Sep 2025 value amounting to $1,000.

  • Biofrontera's Non Operating Investment Income rose 150.00% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$17,000, marking a year-over-year increase of 97.87%. This contributed to the annual value of -$14,000 for FY2024, which is 99.81% up from last year.
  • Per Biofrontera's latest filing, its Non Operating Investment Income stood at $1,000 for Q3 2025, which was up 150.00% from -$2,000 recorded in Q4 2024.
  • In the past 5 years, Biofrontera's Non Operating Investment Income ranged from a high of $1.7 million in Q4 2022 and a low of -$2.9 million during Q1 2023.
  • Moreover, its 3-year median value for Non Operating Investment Income was -$14,000 (2024), whereas its average is -$826,111.
  • In the last 5 years, Biofrontera's Non Operating Investment Income slumped by 144.99% in 2023 and then spiked by 150.00% in 2025.
  • Quarterly analysis of 4 years shows Biofrontera's Non Operating Investment Income stood at $1.7 million in 2022, then tumbled by 144.99% to -$786,000 in 2023, then spiked by 99.75% to -$2,000 in 2024, then spiked by 150.00% to $1,000 in 2025.
  • Its Non Operating Investment Income stands at $1,000 for Q3 2025, versus -$2,000 for Q4 2024 and -$2,000 for Q3 2024.